Publications
53
Citations
640
Est. group size
—
Recurring co-author estimate
Active years
16
Publishing since 2011
Nathaniel W. Mabe studies the molecular biology of neuroblastoma, a childhood cancer, with a focus on epigenetic regulators (proteins that control which genes are turned on or off) and how blocking them can push cancer cells toward a less malignant, more 'differentiated' state. His work also explores how these epigenetic changes can be combined with immunotherapies, such as those targeting the GD2 molecule on tumor cell surfaces, to improve treatment effectiveness.
Publication output has grown over the last decade, rising from about 1 paper per year in 2017 to a much higher pace recently, averaging nearly 7 per year over the last 5 years with a sharp increase in 2026.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Inhibition of USP7 Destabilizes the Noncanonical PRC1.1 Complex and Induces Neuroblastoma Differentiation
Molecular Cancer Research · 2026
- Abstract 7814: Ganglioside targeting: Exerting sweet revenge on neuroblastoma
Cancer Research · 2026
- KMT5C-H4K20me3 drives changes in epigenetic landscape independent of H3K9me3
bioRxiv (Cold Spring Harbor Laboratory) · 2026
- Supplementary Table S1 from Inhibition of USP7 Destabilizes the Noncanonical PRC1.1 Complex and Induces Neuroblastoma Differentiation
2026
- Supplementary Figure S2 from Inhibition of USP7 Destabilizes the Noncanonical PRC1.1 Complex and Induces Neuroblastoma Differentiation
2026
- Supplementary Figure S4 from Inhibition of USP7 Destabilizes the Noncanonical PRC1.1 Complex and Induces Neuroblastoma Differentiation
2026
- Supplementary Figure S6 from Inhibition of USP7 Destabilizes the Noncanonical PRC1.1 Complex and Induces Neuroblastoma Differentiation
2026
- Supplementary Figure S8 from Inhibition of USP7 Destabilizes the Noncanonical PRC1.1 Complex and Induces Neuroblastoma Differentiation
2026
- Data from Inhibition of USP7 Destabilizes the Noncanonical PRC1.1 Complex and Induces Neuroblastoma Differentiation
2026
- Supplementary Figure S1 from Inhibition of USP7 Destabilizes the Noncanonical PRC1.1 Complex and Induces Neuroblastoma Differentiation
2026
- Supplementary Figure S3 from Inhibition of USP7 Destabilizes the Noncanonical PRC1.1 Complex and Induces Neuroblastoma Differentiation
2026
- Supplementary Figure S7 from Inhibition of USP7 Destabilizes the Noncanonical PRC1.1 Complex and Induces Neuroblastoma Differentiation
2026
- Supplementary Figure S5 from Inhibition of USP7 Destabilizes the Noncanonical PRC1.1 Complex and Induces Neuroblastoma Differentiation
2026
- Supplementary Table S2 from Inhibition of USP7 Destabilizes the Noncanonical PRC1.1 Complex and Induces Neuroblastoma Differentiation
2026
- Lineage dependence of the neuroblastoma surfaceome defines tumor cell state-dependent and -independent immunotherapeutic targets
Neuro-Oncology · 2025
- bioRxiv (Cold Spring Harbor Laboratory)×7
- Cancer Research×7
- The FASEB Journal×3
- Nature Cancer×2
- Molecular Cancer Research×2
- Jennifer Sturgis
Medicine · Purdue University West Lafayette
- Tingting Wang
Medicine · The Ohio State University
- Brian Weiss
Medicine · Indiana University
- Keri A. Streby
Medicine · The Ohio State University
- Jennifer H. Aldrink
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 20, 2026.
Claim or correct this profile